Cargando…

Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice

SIMPLE SUMMARY: Chemotherapy-induced cognitive impairment (CICI) is an increasing awareness due to prolonged survival following cancer chemotherapy in cancer patients. Multiple mechanisms have been proposed for CICI induced by various chemotherapeutic agents; however, hippocampal damage and impaired...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Pi-Shan, Chen, Pei-Wen, Yen, Chia-Jui, Shen, Meng-Ru, Chen, Chih-Hung, Tsai, Kuen-Jer, Lin, Chou-Ching K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394018/
https://www.ncbi.nlm.nih.gov/pubmed/34439331
http://dx.doi.org/10.3390/cancers13164177
_version_ 1783743853027655680
author Sung, Pi-Shan
Chen, Pei-Wen
Yen, Chia-Jui
Shen, Meng-Ru
Chen, Chih-Hung
Tsai, Kuen-Jer
Lin, Chou-Ching K.
author_facet Sung, Pi-Shan
Chen, Pei-Wen
Yen, Chia-Jui
Shen, Meng-Ru
Chen, Chih-Hung
Tsai, Kuen-Jer
Lin, Chou-Ching K.
author_sort Sung, Pi-Shan
collection PubMed
description SIMPLE SUMMARY: Chemotherapy-induced cognitive impairment (CICI) is an increasing awareness due to prolonged survival following cancer chemotherapy in cancer patients. Multiple mechanisms have been proposed for CICI induced by various chemotherapeutic agents; however, hippocampal damage and impaired neurogenesis may be one of the mechanisms. The aim of our study was to investigate the interplay between impaired neurogenesis, inflammation, and the symptoms of CICI, including spatial memory dysfunction and mood alteration, in a paclitaxel-treated mice model. In addition, we demonstrated that memantine may serve as a potential therapeutic agent for paclitaxel-induced CICI by modulating neurogenesis and inflammation. However, the treatment regimen may lead to variations in the treatment efficacy, especially in terms of mood dysfunction. Further translational studies may be developed to evaluate the clinical efficacy of memantine in human CICI studies. ABSTRACT: Chemotherapy-induced cognitive impairment (CICI) is an adverse side effect of cancer treatment with increasing awareness. Hippocampal damage and related neurocognitive impairment may mediate the development of CICI, in which altered neurogenesis may play a role. In addition, increased inflammation may be related to chemotherapy-induced hippocampal damage. Memantine, an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that may enhance neurogenesis and modulate inflammation, may be useful for treating CICI. To test this hypothesis, paclitaxel was administered to eight-week-old male B6 mice to demonstrate the relationship between CICI and impaired neurogenesis, and then, we evaluated the impact of different memantine regimens on neurogenesis and inflammation in this CICI model. The results demonstrated that both the pretreatment and cotreatment regimens with memantine successfully reversed impaired neurogenesis and spatial memory impairment in behavior tests. The pretreatment regimen unsuccessfully inhibited the expression of peripheral and central TNF- [Formula: see text] and IL-1 [Formula: see text] and did not improve the mood alterations following paclitaxel treatment. However, the cotreatment regimen led to a better modulatory effect on inflammation and restoration of mood disturbance. In conclusion, this study illustrated that impaired neurogenesis is one of the mechanisms of paclitaxel-induced CICI. Memantine may serve as a potential treatment for paclitaxel-induced CICI, but different treatment strategies may lead to variations in the treatment efficacy.
format Online
Article
Text
id pubmed-8394018
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83940182021-08-28 Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice Sung, Pi-Shan Chen, Pei-Wen Yen, Chia-Jui Shen, Meng-Ru Chen, Chih-Hung Tsai, Kuen-Jer Lin, Chou-Ching K. Cancers (Basel) Article SIMPLE SUMMARY: Chemotherapy-induced cognitive impairment (CICI) is an increasing awareness due to prolonged survival following cancer chemotherapy in cancer patients. Multiple mechanisms have been proposed for CICI induced by various chemotherapeutic agents; however, hippocampal damage and impaired neurogenesis may be one of the mechanisms. The aim of our study was to investigate the interplay between impaired neurogenesis, inflammation, and the symptoms of CICI, including spatial memory dysfunction and mood alteration, in a paclitaxel-treated mice model. In addition, we demonstrated that memantine may serve as a potential therapeutic agent for paclitaxel-induced CICI by modulating neurogenesis and inflammation. However, the treatment regimen may lead to variations in the treatment efficacy, especially in terms of mood dysfunction. Further translational studies may be developed to evaluate the clinical efficacy of memantine in human CICI studies. ABSTRACT: Chemotherapy-induced cognitive impairment (CICI) is an adverse side effect of cancer treatment with increasing awareness. Hippocampal damage and related neurocognitive impairment may mediate the development of CICI, in which altered neurogenesis may play a role. In addition, increased inflammation may be related to chemotherapy-induced hippocampal damage. Memantine, an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that may enhance neurogenesis and modulate inflammation, may be useful for treating CICI. To test this hypothesis, paclitaxel was administered to eight-week-old male B6 mice to demonstrate the relationship between CICI and impaired neurogenesis, and then, we evaluated the impact of different memantine regimens on neurogenesis and inflammation in this CICI model. The results demonstrated that both the pretreatment and cotreatment regimens with memantine successfully reversed impaired neurogenesis and spatial memory impairment in behavior tests. The pretreatment regimen unsuccessfully inhibited the expression of peripheral and central TNF- [Formula: see text] and IL-1 [Formula: see text] and did not improve the mood alterations following paclitaxel treatment. However, the cotreatment regimen led to a better modulatory effect on inflammation and restoration of mood disturbance. In conclusion, this study illustrated that impaired neurogenesis is one of the mechanisms of paclitaxel-induced CICI. Memantine may serve as a potential treatment for paclitaxel-induced CICI, but different treatment strategies may lead to variations in the treatment efficacy. MDPI 2021-08-19 /pmc/articles/PMC8394018/ /pubmed/34439331 http://dx.doi.org/10.3390/cancers13164177 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sung, Pi-Shan
Chen, Pei-Wen
Yen, Chia-Jui
Shen, Meng-Ru
Chen, Chih-Hung
Tsai, Kuen-Jer
Lin, Chou-Ching K.
Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice
title Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice
title_full Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice
title_fullStr Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice
title_full_unstemmed Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice
title_short Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice
title_sort memantine protects against paclitaxel-induced cognitive impairment through modulation of neurogenesis and inflammation in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394018/
https://www.ncbi.nlm.nih.gov/pubmed/34439331
http://dx.doi.org/10.3390/cancers13164177
work_keys_str_mv AT sungpishan memantineprotectsagainstpaclitaxelinducedcognitiveimpairmentthroughmodulationofneurogenesisandinflammationinmice
AT chenpeiwen memantineprotectsagainstpaclitaxelinducedcognitiveimpairmentthroughmodulationofneurogenesisandinflammationinmice
AT yenchiajui memantineprotectsagainstpaclitaxelinducedcognitiveimpairmentthroughmodulationofneurogenesisandinflammationinmice
AT shenmengru memantineprotectsagainstpaclitaxelinducedcognitiveimpairmentthroughmodulationofneurogenesisandinflammationinmice
AT chenchihhung memantineprotectsagainstpaclitaxelinducedcognitiveimpairmentthroughmodulationofneurogenesisandinflammationinmice
AT tsaikuenjer memantineprotectsagainstpaclitaxelinducedcognitiveimpairmentthroughmodulationofneurogenesisandinflammationinmice
AT linchouchingk memantineprotectsagainstpaclitaxelinducedcognitiveimpairmentthroughmodulationofneurogenesisandinflammationinmice